Published in J Neurooncol on February 14, 2013
Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol (2014) 4.10
Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol (2014) 1.08
Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study. Eur Arch Otorhinolaryngol (2013) 0.90
Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol (2014) 0.89
Clinical and scientific impact of human papillomavirus on head and neck cancer. World J Clin Oncol (2014) 0.83
Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomes. Oral Oncol (2013) 0.82
A survey on pulmonary screening practices among otolaryngology-head & neck surgeons across Canada in the post treatment surveillance of head and neck squamous cell carcinoma. J Otolaryngol Head Neck Surg (2015) 0.81
Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer. Cancer (2015) 0.81
Understanding the impact of survival and human papillomavirus tumor status on timing of recurrence in oropharyngeal squamous cell carcinoma. Oral Oncol (2015) 0.81
The Fidelity of p16 Staining as a Surrogate Marker of Human Papillomavirus Status in Fine-Needle Aspirates and Core Biopsies of Neck Node Metastases: Implications for HPV Testing Protocols. Acta Cytol (2015) 0.79
mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC. Oncotarget (2016) 0.78
Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins. Clin Cancer Res (2015) 0.77
Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis. Oncotarget (2016) 0.76
An extremely rare, remote intracerebral metastasis of oral cavity cancer: a case report. Case Rep Med (2013) 0.76
Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis. Mol Clin Oncol (2016) 0.75
Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysis. J Neurooncol (2017) 0.75
Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74
Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst (2008) 8.70
HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol (2010) 6.53
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck (2009) 2.59
Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res (2005) 2.32
Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol (2009) 1.88
Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis (2010) 1.85
Head and neck cancer: changing epidemiology and public health implications. Oncology (Williston Park) (2010) 1.77
Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol (2012) 1.72
Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg (2006) 1.71
Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope (2007) 1.61
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope (2001) 1.59
Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.49
Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck (2000) 1.27
HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior. Am J Surg Pathol (2012) 1.22
HPV positive squamous cell carcinoma of the oropharynx. Are we observing an unusual pattern of metastases? Head Neck Pathol (2012) 1.21
Patterns of spread of distant metastases in head and neck cancer. Cancer (1974) 1.15
HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol (2012) 1.14
Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. Oral Oncol (2012) 1.10
Intracranial metastases in patients with squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg (2001) 0.99
Distant metastases from head and neck cancer. Cancer (1984) 0.95
Management of advanced stage squamous cell carcinoma of the head and neck. Am J Med Sci (1986) 0.90
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature (2006) 7.69
AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A (2000) 4.37
Mandatory second opinion surgical pathology at a large referral hospital. Cancer (1999) 3.40
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res (1996) 3.18
Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res (1996) 1.80
Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst (1998) 1.78
Serial analysis of gene expression in non-small cell lung cancer. Cancer Res (1998) 1.67
Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck (2000) 1.51
Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res (2000) 1.46
Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res (2001) 1.39
Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res (1998) 1.39
PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol (1999) 1.36
Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res (2001) 1.34
Intrabiliary growth of metastatic colonic adenocarcinoma: a pattern of intrahepatic spread easily confused with primary neoplasia of the biliary tract. Am J Surg Pathol (1997) 1.33
p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst (1996) 1.32
Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res (2009) 1.31
Imaging findings of a hibernoma of the neck. AJNR Am J Neuroradiol (2006) 1.28
Quantitative assessment of promoter methylation profiles in thyroid neoplasms. J Clin Endocrinol Metab (2005) 1.27
Intratumoral chemotherapy. Neurosurgery (1995) 1.25
Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg (2001) 1.22
Visual and electrical evoked response recorded from subdural electrodes implanted above the visual cortex in normal dogs under two methods of anesthesia. J Neurosci Methods (2003) 1.18
Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res (2000) 1.15
Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst (1999) 1.13
Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol (1999) 1.11
Langerhans cell histiocytosis of the thyroid: a report of two cases and review of the literature. Thyroid (2001) 1.11
Allelotype of salivary gland tumors. Cancer Res (1996) 1.10
Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin Cancer Res (1999) 1.09
Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res (1996) 1.08
Occult tonsillar carcinoma in the unknown primary. Laryngoscope (1998) 1.05
Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res (1997) 1.05
Inverted sinonasal papilloma : a molecular genetic appraisal of its putative status as a Precursor to squamous cell carcinoma. Am J Pathol (2000) 1.03
Slit-ventricle syndrome: review of 15 cases. Pediatr Neurosci (1987) 1.01
The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth. Oncogene (2007) 1.00
Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res (1999) 1.00
Papillary carcinoma of the thyroid: can operative management be based solely on fine-needle aspiration? J Am Coll Surg (1997) 1.00
Multidisciplinary treatment of medulloblastoma: a 5-year experience with the SIOP trial. Childs Brain (1981) 0.99
HIV-associated primary CNS lymorbidity and utility of brain biopsy. J Neurol Sci (1999) 0.98
The expanding clinical spectrum of desmoplastic small round-cell tumor: a report of two cases with molecular confirmation. Hum Pathol (1999) 0.98
Metastasizing mixed tumor of the parotid: initial presentation as a solitary kidney tumor and ultimate carcinomatous transformation at the primary site. Am J Surg Pathol (2000) 0.98
Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Cancer Res (2001) 0.98
Ectopic lingual thyroid masquerading as thyroid cancer metastases. J Clin Endocrinol Metab (2001) 0.97
Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene (1999) 0.97
Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Clin Cancer Res (1999) 0.97
Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer (1998) 0.97
Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. Clin Cancer Res (1997) 0.97
Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases. Hum Pathol (2002) 0.96
Use of technetium Tc 99m sestamibi scintigraphy for recurrent tertiary hyperparathyroidism from a parathyroid forearm graft. South Med J (2000) 0.96
Reversible posterior leukoencephalopathy occurring during resection of a posterior fossa tumor: case report and review of the literature. Neurosurgery (2001) 0.96
p53 alterations in atypical alveolar hyperplasia of the human lung. Hum Pathol (1998) 0.95
Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene (1999) 0.95
Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization. Int J Cancer (1997) 0.95
Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. J Neurosurg (1994) 0.95
Intracranial leiomyosarcoma in a patient with AIDS. Neuroradiology (1999) 0.94
Intraventricular rupture of a purulent brain abscess: case report. Neurosurgery (1995) 0.94
Myosin heavy chain composition in human laryngeal muscles. Laryngoscope (1999) 0.92
Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid. J Clin Endocrinol Metab (1998) 0.91
Microsatellite instability in primary neoplasms from HIV + patients. Nat Med (1995) 0.91
Static image analysis of skin specimens: the application of telepathology to frozen section evaluation. Hum Pathol (1997) 0.91
Paraganglioma of the thyroid: two cases that clarify and expand the clinical spectrum. Head Neck (2000) 0.89
A putative oncogenic role for MPP11 in head and neck squamous cell cancer. Cancer Res (2000) 0.89
Well-differentiated papillary adenocarcinoma arising in a supratentorial enterogenous cyst: case report. Neurosurgery (1998) 0.89
Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles. J Pharm Sci (1994) 0.89
Transitional cell carcinoma presenting as a solitary brain lesion: a case report and review of the world literature. J Neurooncol (1998) 0.89
Corticotropin-independent Cushing's syndrome caused by an ectopic adrenal adenoma. J Clin Endocrinol Metab (2000) 0.89
Lymphoid infiltrates of the salivary glands: pathology, biology and clinical significance. Curr Opin Oncol (1996) 0.88
Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome presenting as a primary calvarial lesion. Case report and review of the literature. J Neurosurg (2000) 0.87
The supraorbital craniotomy for access to the skull base and intraaxial lesions: a technique in evolution. Minim Invasive Neurosurg (2010) 0.87
EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer. Eur Respir J (2006) 0.86
Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes. Br J Cancer (2012) 0.86
Bone metastasis from breast carcinoma with fluid-fluid level. Skeletal Radiol (1996) 0.84
Coinfection of HPV-11 and HPV-16 in a case of laryngeal squamous papillomas with severe dysplasia. Laryngoscope (1997) 0.84
Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. J Neurosurg (1995) 0.84
Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer. Clin Cancer Res (1997) 0.83
Giant cell reparative granuloma of the sphenoid bone. AJNR Am J Neuroradiol (2006) 0.83
Ictus expectoratus: a sign of complex partial seizures usually of non-dominant temporal lobe origin. Seizure (1999) 0.83
Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms. Clin Cancer Res (1996) 0.83
Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology (1997) 0.82
Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid. Surgery (1997) 0.82
Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodiles. J Natl Cancer Inst (1998) 0.81
Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: a potentially preventable complication. J Neurooncol (1997) 0.81
Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. J Neurosurg (2000) 0.81
Cervical intramedullary hemorrhage as a result of anticoagulant therapy. J Spinal Disord (1993) 0.81
Pathologic quiz case 1. Solitary fibrous tumor (SFT) of the orbit. Arch Otolaryngol Head Neck Surg (1996) 0.81
Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer. Arch Otolaryngol Head Neck Surg (1997) 0.80
Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clin Cancer Res (2001) 0.80
Cystic prostate metastases to the brain parenchyma: report of two cases and review of the literature. J Neurooncol (2001) 0.80
An allelotype of papillary thyroid cancer. Int J Cancer (1996) 0.79
Multiple intracranial aneurysms in identical twins. Acta Neurochir (Wien) (1988) 0.79
PSA immunoreactivity in a parotid oncocytoma: a diagnostic pitfall in discriminating primary parotid neoplasms from metastatic prostate cancer. Diagn Cytopathol (1998) 0.79
Hypoxic sensitizer and cytotoxin for head and neck cancer. Ann Acad Med Singapore (1996) 0.78
Metastatic renal cell carcinoma to the pituitary presenting with hyperprolactinemia. J Endocrinol Invest (2004) 0.78
The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma. Cancer Res (1999) 0.78
Long-term immunological investigation of malignant intracranial gliomas. Surg Neurol (1981) 0.78
HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol (2000) 0.77
Sialoblastoma: association with cutaneous hamartoma (organoid nevus)? Pediatr Dev Pathol (2000) 0.76
Spinal meningioma causing diffuse leptomeningeal enhancement. Neurology (2003) 0.76
Transformation of rat thyroid follicular cells stably transfected with cholera toxin A1 fragment. Endocrinology (1996) 0.76
Solitary plasmacytoma of the epiglottis: a case report and review of the literature. J Laryngol Otol (1998) 0.76
Loss of chromosome arms 3p and 9p and inactivation of P16 (INK4a) in normal epithelium of patients with primary lung cancer. Genes Chromosomes Cancer (2001) 0.76